These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 4765746

  • 1. 6-Hydroxydopamine: effect on mouse brain monoamines and 14C-noradrenaline uptake.
    Masuoka DT, Alcaraz AF.
    Eur J Pharmacol; 1973 Nov; 24(2):234-42. PubMed ID: 4765746
    [No Abstract] [Full Text] [Related]

  • 2. Chemical lesioning of central monoamine axons by means of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine.
    Björklund A, Baumgarten HG, Nobin A.
    Adv Biochem Psychopharmacol; 1974 Nov; 10():13-33. PubMed ID: 4846535
    [No Abstract] [Full Text] [Related]

  • 3. Studies on brain monoamine and neuropeptide systems after neonatal intracerebroventricular 6-hydroxydopamine treatment.
    Luthman J, Brodin E, Sundström E, Wiehager B.
    Int J Dev Neurosci; 1990 Nov; 8(5):549-60. PubMed ID: 1704172
    [Abstract] [Full Text] [Related]

  • 4. Neuronal degeneration in rat brain induced by 6-hydroxydopamine; a histological and biochemical study.
    Hedreen JC, Chalmers JP.
    Brain Res; 1972 Nov 27; 47(1):1-36. PubMed ID: 4345031
    [No Abstract] [Full Text] [Related]

  • 5. Changes in central noradrenaline neurons after systemic 6-hydroxydopamine administration.
    Sachs C, Jonsson G.
    J Neurochem; 1973 Dec 27; 21(6):1517-24. PubMed ID: 4771442
    [No Abstract] [Full Text] [Related]

  • 6. The inhibition of 3 H-biogenic amine uptake by 5,6-dihydroxytryptamine: a comparison with the effects of 6-hydroxydopamine.
    Heikkila RE, Cohen G.
    Eur J Pharmacol; 1973 Jan 27; 21(1):66-9. PubMed ID: 4709207
    [No Abstract] [Full Text] [Related]

  • 7. Noradrenaline nerve terminals in the cerebral cortex: effects on noradrenaline uptake and storage following axonal lesion with 6-hydroxydopamine.
    Lidbrink P, Jonsson G.
    J Neurochem; 1974 May 27; 22(5):617-26. PubMed ID: 4152079
    [No Abstract] [Full Text] [Related]

  • 8. Changes in the development of central noradrenaline neurones following neonatal administration of 6-hydroxydopamine.
    Jonsson G, Pycock C, Fuxe K, Sachs C.
    J Neurochem; 1974 Mar 27; 22(3):419-26. PubMed ID: 4829965
    [No Abstract] [Full Text] [Related]

  • 9. Release of biogenic amines from isolated nerve endings.
    Raiteri M, Bertollini A, del Carmine R, Levi G.
    Adv Exp Med Biol; 1976 Mar 27; 69():319-35. PubMed ID: 941741
    [No Abstract] [Full Text] [Related]

  • 10. Uptake of 5-hydroxytryptamine by Schistosoma mansoni.
    Bennett JL, Bueding E.
    Mol Pharmacol; 1973 May 27; 9(3):311-9. PubMed ID: 4267956
    [No Abstract] [Full Text] [Related]

  • 11. Ontogeny of monoamine neurons in the locus coeruleus, Raphe nuclei and substantia nigra of the rat. I. Cell differentiation.
    Lauder JM, Bloom FE.
    J Comp Neurol; 1974 Jun 15; 155(4):469-81. PubMed ID: 4847734
    [No Abstract] [Full Text] [Related]

  • 12. [Effects of the intraventricular injection of 6-hydroxydopamine. I. On the cerebral monoamines of the cat].
    Petitjean F, Laguzzi R, Sordet F, Jouvet M, Pujol JF.
    Brain Res; 1972 Dec 24; 48():281-93. PubMed ID: 4645209
    [No Abstract] [Full Text] [Related]

  • 13. Role of brain monoamines in the anorectic activity of mazindol and d-amphetamine in the rat.
    Samanin R, Bendotti C, Bernasconi S, Borroni E, Garattini S.
    Eur J Pharmacol; 1977 May 15; 43(2):117-24. PubMed ID: 872869
    [Abstract] [Full Text] [Related]

  • 14. Depletion of brain norepinephrine by intraventricular injection of 6-hydroxydopa: a biochemical, histochemical and behavioral study in rats.
    Richardson JS, Jacobowitz DM.
    Brain Res; 1973 Aug 17; 58(1):117-33. PubMed ID: 4740976
    [No Abstract] [Full Text] [Related]

  • 15. Selective (+)-amphetamine neurotoxicity on striatal dopamine nerve terminals in the mouse.
    Jonsson G, Nwanze E.
    Br J Pharmacol; 1982 Oct 17; 77(2):335-45. PubMed ID: 7139192
    [Abstract] [Full Text] [Related]

  • 16. Drug-induced brain monoamine depletion and its behavioral correlates in Caiman sclerops.
    Doshi E, Huggins SE.
    Comp Biochem Physiol C Comp Pharmacol; 1977 Oct 17; 57(2):153-7. PubMed ID: 20272
    [No Abstract] [Full Text] [Related]

  • 17. Biogenic amine terminals in the goldfish cerebellum and optic tectum: a fluorescence and autoradiographic study.
    Niso R, Villani L, Contestabile A, Ciani F.
    Basic Appl Histochem; 1981 Oct 17; 25(2):113-9. PubMed ID: 7271702
    [Abstract] [Full Text] [Related]

  • 18. Developmental characteristics of central monoamine neurons and their reciprocal relations.
    Jonsson G.
    Exp Neurol; 1976 Dec 17; 53(3):801-14. PubMed ID: 1001399
    [No Abstract] [Full Text] [Related]

  • 19. [Localization of biogenic amines in the rat spinal cord. A fluorescence histochemical study after intraventricular injection of L-dopa (author's transl)].
    Chouchkov CN.
    Histochemistry; 1974 Dec 17; 41(2):167-73. PubMed ID: 4374457
    [No Abstract] [Full Text] [Related]

  • 20. Effect of a butyrophenone derivative, U-32,802A, on brain biogenic amines.
    Lahti RA, Lednicer D.
    Biochem Pharmacol; 1974 Jun 15; 23(12):1701-5. PubMed ID: 4842658
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.